Company intelligence / Profile preview

BioFlyte

Albuquerque, New Mexico, United States

Ownership: Private
Development stage: Other

Overview

BioFlyte's BioTOF z200 device is commercially deployed for real-time air monitoring and detection of biological and chemical threats, including successful field validation at transportation and critical infrastructure sites.[3][5][7]

Therapeutic areas: OtherInfectious Diseases
Modalities: Device
Industry: Molecular Diagnostics

Partnerships

Pentagon Force Protection AgencyPittsburgh International AirportSoBran, Inc.

Beyond the preview

Go deeper on BioFlyte.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioFlyte.

Explore the full profile